MARRAS, FRANCESCO
MARRAS, FRANCESCO
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control
2017-01-01 Malnati, M. S.; Ugolotti, E.; Monti, M. C.; De Battista, D.; Vanni, I.; Bordo, D.; Sironi, F.; Larghero, P.; Di Marco, E.; Biswas, P.; Poli, G.; Vicenzi, E.; Riva, A.; Tarkowski, M.; Tambussi, G.; Nozza, S.; Tripodi, G.; Marras, F.; De Maria, A.; Pistorio, A.; Biassoni, R.
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
2011-01-01 Bozzano, F; Picciotto, Antonino; Costa, P; Marras, Francesco; Fazio, V; Hirsch, I; Olive, D; Moretta, Lorenzo; DE MARIA, Andrea
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells
2017-01-01 Marras, Francesco; Casabianca, Anna; Bozzano, Federica; Ascierto, Maria Libera; Orlandi, Chiara; Di Biagio, Antonio; Pontali, Emanuele; Dentone, Chiara; Orofino, Giancarlo; Nicolini, Laura; Taramasso, Lucia; Magnani, Mauro; Marincola, Francesco M.; Wang, Ena; Moretta, Lorenzo; De Maria, Andrea
Immunological profile of an infant treated with integrase inhibitor from the neonatal period
2019-01-01 Taramasso, Lucia; Dentone, Chiara; Tatarelli, Paola; Bruzzone, Bianca; Marras, Francesco; De Maria, Andrea; Gotta, Cristina; Castagnola, Elio; Filaci, Gilberto; Viscoli, Claudio; Fenoglio, Daniela; Di Biagio, Antonio
Natural killer cell development and maturation revisited: Possible implications of a novel distinct Lin-CD34+DNAM-1brightCXCR4+ cell progenitor
2017-01-01 Bozzano, Federica; Marras, Francesco; DE MARIA, Andrea
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.
2013-01-01 Marras, Francesco; Nicco, E; Bozzano, Federica; Di Biagio, A; Dentone, C; Pontali, E; Boni, S; Setti, M; Orofino, G; Mantia, E; Bartolacci, V; Bisio, F; Riva, A; Biassoni, Roberto; Moretta, Lorenzo; DE MARIA, Andrea
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption.
2011-01-01 Bozzano, F; Nasi, M; Bertoncelli, L; Nemes, E; Prati, F; Marras, Francesco; Mussini, C; Moretta, Lorenzo; Cossarizza, A; DE MARIA, Andrea
Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG).
2012-01-01 Marras, Francesco; Bozzano, F; Bentivoglio, Giorgio; Ugolotti, E; Biassoni, R; Moretta, Lorenzo; DE MARIA, Andrea
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL
2014-01-01 Dentone, Chiara; Fenoglio, Daniela; Signori, Alessio; Cenderello, G.; Parodi, Alessia; Bozzano, Federica; Guerra, M.; De Leo, P.; Bartolacci, V.; Mantia, E.; Orofino, G.; Kalli, Francesca; Marras, Francesco; Fraccaro, Paolo; Giacomini, Mauro; Cassola, G.; Bruzzone, B.; Ferrea, G.; Viscoli, Claudio; Filaci, G.; DE MARIA, Andrea; Di Biagio, A.
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation.
2013-01-01 Bisio, F; Bozzano, Federica; Marras, Francesco; Di Biagio, A; Moretta, Lorenzo; DE MARIA, Andrea
Use of maraviroc in clinical practice: a multicenter observational study
2012-01-01 Dentone, Chiara; Fraccaro, Paolo; Fenoglio, Daniela; Firpo, E.; Cenderello, G.; Piscopo, R.; Cassola, G.; Bertolacci, V.; Casalino Finocchio, G.; De Leo, P.; Guerra, M.; Orofino, G.; Mantia, E.; Zoppi, M.; Filaci, Gilberto; Parodi, Alessia; DE MARIA, Andrea; Bozzano, Federica; Marras, Francesco; Sormani, MARIA PIA; Signori, Alessio; Bruzzone, B.; Nigro, N.; Ferrea, G.; Giacomini, Mauro; Viscoli, Claudio; Di Biagio, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control | 1-gen-2017 | Malnati, M. S.; Ugolotti, E.; Monti, M. C.; De Battista, D.; Vanni, I.; Bordo, D.; Sironi, F.; Larghero, P.; Di Marco, E.; Biswas, P.; Poli, G.; Vicenzi, E.; Riva, A.; Tarkowski, M.; Tambussi, G.; Nozza, S.; Tripodi, G.; Marras, F.; De Maria, A.; Pistorio, A.; Biassoni, R. | |
| Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. | 1-gen-2011 | Bozzano, F; Picciotto, Antonino; Costa, P; Marras, Francesco; Fazio, V; Hirsch, I; Olive, D; Moretta, Lorenzo; DE MARIA, Andrea | |
| Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells | 1-gen-2017 | Marras, Francesco; Casabianca, Anna; Bozzano, Federica; Ascierto, Maria Libera; Orlandi, Chiara; Di Biagio, Antonio; Pontali, Emanuele; Dentone, Chiara; Orofino, Giancarlo; Nicolini, Laura; Taramasso, Lucia; Magnani, Mauro; Marincola, Francesco M.; Wang, Ena; Moretta, Lorenzo; De Maria, Andrea | |
| Immunological profile of an infant treated with integrase inhibitor from the neonatal period | 1-gen-2019 | Taramasso, Lucia; Dentone, Chiara; Tatarelli, Paola; Bruzzone, Bianca; Marras, Francesco; De Maria, Andrea; Gotta, Cristina; Castagnola, Elio; Filaci, Gilberto; Viscoli, Claudio; Fenoglio, Daniela; Di Biagio, Antonio | |
| Natural killer cell development and maturation revisited: Possible implications of a novel distinct Lin-CD34+DNAM-1brightCXCR4+ cell progenitor | 1-gen-2017 | Bozzano, Federica; Marras, Francesco; DE MARIA, Andrea | |
| Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. | 1-gen-2013 | Marras, Francesco; Nicco, E; Bozzano, Federica; Di Biagio, A; Dentone, C; Pontali, E; Boni, S; Setti, M; Orofino, G; Mantia, E; Bartolacci, V; Bisio, F; Riva, A; Biassoni, Roberto; Moretta, Lorenzo; DE MARIA, Andrea | |
| NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. | 1-gen-2011 | Bozzano, F; Nasi, M; Bertoncelli, L; Nemes, E; Prati, F; Marras, Francesco; Mussini, C; Moretta, Lorenzo; Cossarizza, A; DE MARIA, Andrea | |
| Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG). | 1-gen-2012 | Marras, Francesco; Bozzano, F; Bentivoglio, Giorgio; Ugolotti, E; Biassoni, R; Moretta, Lorenzo; DE MARIA, Andrea | |
| Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL | 1-gen-2014 | Dentone, Chiara; Fenoglio, Daniela; Signori, Alessio; Cenderello, G.; Parodi, Alessia; Bozzano, Federica; Guerra, M.; De Leo, P.; Bartolacci, V.; Mantia, E.; Orofino, G.; Kalli, Francesca; Marras, Francesco; Fraccaro, Paolo; Giacomini, Mauro; Cassola, G.; Bruzzone, B.; Ferrea, G.; Viscoli, Claudio; Filaci, G.; DE MARIA, Andrea; Di Biagio, A. | |
| Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. | 1-gen-2013 | Bisio, F; Bozzano, Federica; Marras, Francesco; Di Biagio, A; Moretta, Lorenzo; DE MARIA, Andrea | |
| Use of maraviroc in clinical practice: a multicenter observational study | 1-gen-2012 | Dentone, Chiara; Fraccaro, Paolo; Fenoglio, Daniela; Firpo, E.; Cenderello, G.; Piscopo, R.; Cassola, G.; Bertolacci, V.; Casalino Finocchio, G.; De Leo, P.; Guerra, M.; Orofino, G.; Mantia, E.; Zoppi, M.; Filaci, Gilberto; Parodi, Alessia; DE MARIA, Andrea; Bozzano, Federica; Marras, Francesco; Sormani, MARIA PIA; Signori, Alessio; Bruzzone, B.; Nigro, N.; Ferrea, G.; Giacomini, Mauro; Viscoli, Claudio; Di Biagio, A. |